Inhibition of miR-181a expression in ALL cells revealed an influence on CD4 and HMGB1 (high-mobility group box 1 protein) levels, indicating a possible role of miR-181a in immunogenicity [157]. The gene discussed is HMGB1; the disease is acute lymphoblastic leukemia.